Loading…
Evaluating the effects of 2-BFI and tracizoline, two potent I 2 -imidazoline receptor agonists, on cognitive performance and affect in middle-aged rats
Cognitive performance and affective-like responses are particularly susceptible to decline during the aging process. Since imidazoline receptors I are altered in neurodegenerative and psychiatric disorders, the pharmacological modulation of I receptors could be of potential interest to improve these...
Saved in:
Published in: | Naunyn-Schmiedeberg's archives of pharmacology 2021-05, Vol.394 (5), p.989 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | |
container_issue | 5 |
container_start_page | 989 |
container_title | Naunyn-Schmiedeberg's archives of pharmacology |
container_volume | 394 |
creator | Hernández-Hernández, Elena García-Fuster, M Julia |
description | Cognitive performance and affective-like responses are particularly susceptible to decline during the aging process. Since imidazoline receptors I
are altered in neurodegenerative and psychiatric disorders, the pharmacological modulation of I
receptors could be of potential interest to improve these age-related behavioral deficits. In this context, the present study explored the potential pro-cognitive as well as antidepressant-like effects of two potent I
agonists, 2-BFI (2-(2-benzofuranyl)-2-imidazoline), and tracizoline (2-styryl-4,5-dihydro-lH-imidazole, also known as LSL 61122 or valldemossine) in middle-aged male rats. Following a preliminary study performed to select a dose regimen capable of inducing neuroplastic events (i.e., regulation of hippocampal FADD cell fate adaptor), 2-BFI or tracizoline (10 mg/kg, i.p.) was administered to 9-10-month-old Sprague-Dawley rats. Cognitive performance was evaluated in the 8-arm radial maze and antidepressant-like responses under the stress of the forced-swim test. At the dose selected, 2-BFI and tracizoline did not alter body weight or cognitive performance. Interestingly, 2-BFI (but not tracizoline) induced hypothermia over the course of treatment and an antidepressant-like response in the forced-swim test. These compounds did not improve cognitive performance in middle-aged rats; however, 2-BFI exerted an antidepressant-like response. These results are in line with prior reports suggesting a beneficial impact induced by certain I
ligands on affective-like behavior, while adding that the beneficial effects were mediated by increasing climbing behavior and with the novelty and importance of demonstrating this effect for middle-aged rats. |
doi_str_mv | 10.1007/s00210-020-02042-6 |
format | article |
fullrecord | <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_33415506</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>33415506</sourcerecordid><originalsourceid>FETCH-LOGICAL-p108t-c361a7fdac64cdb767b9adb0196340ad1fb1dc5bf73560a42234fbb0fcc899263</originalsourceid><addsrcrecordid>eNo1kEtKA0EYhBtBTIxewIX8B0hrP2Z6MksNiQYCbnQd_n6NLZPuYaYT0Yt4XUOii6IKCr6CIuSGszvOWHU_MCY4o0wcVQiqzsiYF1JQXnMxIpfD8MEYU7wsL8hIyuIQmBqTn8Ue2x3mEBvI7w6c987kAZIHQR-XK8BoIfdowndqQ3RTyJ8JupRdzLACATRsg8VTCb0zrsupB2xSDEMeppAimNTEkMPeQed6n_otRuOOYDyuQYhwgNjWUWychR7zcEXOPbaDu_7zCXlbLl7nz3T98rSaP6xpx9ksUyMVx8pbNKowVleq0jVazXitZMHQcq-5NaX2lSwVw0IIWXitmTdmVtdCyQm5PXG7nd46u-n6sMX-a_P_kPwFkU5o8g</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Evaluating the effects of 2-BFI and tracizoline, two potent I 2 -imidazoline receptor agonists, on cognitive performance and affect in middle-aged rats</title><source>Springer Nature</source><creator>Hernández-Hernández, Elena ; García-Fuster, M Julia</creator><creatorcontrib>Hernández-Hernández, Elena ; García-Fuster, M Julia</creatorcontrib><description>Cognitive performance and affective-like responses are particularly susceptible to decline during the aging process. Since imidazoline receptors I
are altered in neurodegenerative and psychiatric disorders, the pharmacological modulation of I
receptors could be of potential interest to improve these age-related behavioral deficits. In this context, the present study explored the potential pro-cognitive as well as antidepressant-like effects of two potent I
agonists, 2-BFI (2-(2-benzofuranyl)-2-imidazoline), and tracizoline (2-styryl-4,5-dihydro-lH-imidazole, also known as LSL 61122 or valldemossine) in middle-aged male rats. Following a preliminary study performed to select a dose regimen capable of inducing neuroplastic events (i.e., regulation of hippocampal FADD cell fate adaptor), 2-BFI or tracizoline (10 mg/kg, i.p.) was administered to 9-10-month-old Sprague-Dawley rats. Cognitive performance was evaluated in the 8-arm radial maze and antidepressant-like responses under the stress of the forced-swim test. At the dose selected, 2-BFI and tracizoline did not alter body weight or cognitive performance. Interestingly, 2-BFI (but not tracizoline) induced hypothermia over the course of treatment and an antidepressant-like response in the forced-swim test. These compounds did not improve cognitive performance in middle-aged rats; however, 2-BFI exerted an antidepressant-like response. These results are in line with prior reports suggesting a beneficial impact induced by certain I
ligands on affective-like behavior, while adding that the beneficial effects were mediated by increasing climbing behavior and with the novelty and importance of demonstrating this effect for middle-aged rats.</description><identifier>EISSN: 1432-1912</identifier><identifier>DOI: 10.1007/s00210-020-02042-6</identifier><identifier>PMID: 33415506</identifier><language>eng</language><publisher>Germany</publisher><ispartof>Naunyn-Schmiedeberg's archives of pharmacology, 2021-05, Vol.394 (5), p.989</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-9177-3775</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33415506$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hernández-Hernández, Elena</creatorcontrib><creatorcontrib>García-Fuster, M Julia</creatorcontrib><title>Evaluating the effects of 2-BFI and tracizoline, two potent I 2 -imidazoline receptor agonists, on cognitive performance and affect in middle-aged rats</title><title>Naunyn-Schmiedeberg's archives of pharmacology</title><addtitle>Naunyn Schmiedebergs Arch Pharmacol</addtitle><description>Cognitive performance and affective-like responses are particularly susceptible to decline during the aging process. Since imidazoline receptors I
are altered in neurodegenerative and psychiatric disorders, the pharmacological modulation of I
receptors could be of potential interest to improve these age-related behavioral deficits. In this context, the present study explored the potential pro-cognitive as well as antidepressant-like effects of two potent I
agonists, 2-BFI (2-(2-benzofuranyl)-2-imidazoline), and tracizoline (2-styryl-4,5-dihydro-lH-imidazole, also known as LSL 61122 or valldemossine) in middle-aged male rats. Following a preliminary study performed to select a dose regimen capable of inducing neuroplastic events (i.e., regulation of hippocampal FADD cell fate adaptor), 2-BFI or tracizoline (10 mg/kg, i.p.) was administered to 9-10-month-old Sprague-Dawley rats. Cognitive performance was evaluated in the 8-arm radial maze and antidepressant-like responses under the stress of the forced-swim test. At the dose selected, 2-BFI and tracizoline did not alter body weight or cognitive performance. Interestingly, 2-BFI (but not tracizoline) induced hypothermia over the course of treatment and an antidepressant-like response in the forced-swim test. These compounds did not improve cognitive performance in middle-aged rats; however, 2-BFI exerted an antidepressant-like response. These results are in line with prior reports suggesting a beneficial impact induced by certain I
ligands on affective-like behavior, while adding that the beneficial effects were mediated by increasing climbing behavior and with the novelty and importance of demonstrating this effect for middle-aged rats.</description><issn>1432-1912</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNo1kEtKA0EYhBtBTIxewIX8B0hrP2Z6MksNiQYCbnQd_n6NLZPuYaYT0Yt4XUOii6IKCr6CIuSGszvOWHU_MCY4o0wcVQiqzsiYF1JQXnMxIpfD8MEYU7wsL8hIyuIQmBqTn8Ue2x3mEBvI7w6c987kAZIHQR-XK8BoIfdowndqQ3RTyJ8JupRdzLACATRsg8VTCb0zrsupB2xSDEMeppAimNTEkMPeQed6n_otRuOOYDyuQYhwgNjWUWychR7zcEXOPbaDu_7zCXlbLl7nz3T98rSaP6xpx9ksUyMVx8pbNKowVleq0jVazXitZMHQcq-5NaX2lSwVw0IIWXitmTdmVtdCyQm5PXG7nd46u-n6sMX-a_P_kPwFkU5o8g</recordid><startdate>202105</startdate><enddate>202105</enddate><creator>Hernández-Hernández, Elena</creator><creator>García-Fuster, M Julia</creator><scope>NPM</scope><orcidid>https://orcid.org/0000-0002-9177-3775</orcidid></search><sort><creationdate>202105</creationdate><title>Evaluating the effects of 2-BFI and tracizoline, two potent I 2 -imidazoline receptor agonists, on cognitive performance and affect in middle-aged rats</title><author>Hernández-Hernández, Elena ; García-Fuster, M Julia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p108t-c361a7fdac64cdb767b9adb0196340ad1fb1dc5bf73560a42234fbb0fcc899263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hernández-Hernández, Elena</creatorcontrib><creatorcontrib>García-Fuster, M Julia</creatorcontrib><collection>PubMed</collection><jtitle>Naunyn-Schmiedeberg's archives of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hernández-Hernández, Elena</au><au>García-Fuster, M Julia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluating the effects of 2-BFI and tracizoline, two potent I 2 -imidazoline receptor agonists, on cognitive performance and affect in middle-aged rats</atitle><jtitle>Naunyn-Schmiedeberg's archives of pharmacology</jtitle><addtitle>Naunyn Schmiedebergs Arch Pharmacol</addtitle><date>2021-05</date><risdate>2021</risdate><volume>394</volume><issue>5</issue><spage>989</spage><pages>989-</pages><eissn>1432-1912</eissn><abstract>Cognitive performance and affective-like responses are particularly susceptible to decline during the aging process. Since imidazoline receptors I
are altered in neurodegenerative and psychiatric disorders, the pharmacological modulation of I
receptors could be of potential interest to improve these age-related behavioral deficits. In this context, the present study explored the potential pro-cognitive as well as antidepressant-like effects of two potent I
agonists, 2-BFI (2-(2-benzofuranyl)-2-imidazoline), and tracizoline (2-styryl-4,5-dihydro-lH-imidazole, also known as LSL 61122 or valldemossine) in middle-aged male rats. Following a preliminary study performed to select a dose regimen capable of inducing neuroplastic events (i.e., regulation of hippocampal FADD cell fate adaptor), 2-BFI or tracizoline (10 mg/kg, i.p.) was administered to 9-10-month-old Sprague-Dawley rats. Cognitive performance was evaluated in the 8-arm radial maze and antidepressant-like responses under the stress of the forced-swim test. At the dose selected, 2-BFI and tracizoline did not alter body weight or cognitive performance. Interestingly, 2-BFI (but not tracizoline) induced hypothermia over the course of treatment and an antidepressant-like response in the forced-swim test. These compounds did not improve cognitive performance in middle-aged rats; however, 2-BFI exerted an antidepressant-like response. These results are in line with prior reports suggesting a beneficial impact induced by certain I
ligands on affective-like behavior, while adding that the beneficial effects were mediated by increasing climbing behavior and with the novelty and importance of demonstrating this effect for middle-aged rats.</abstract><cop>Germany</cop><pmid>33415506</pmid><doi>10.1007/s00210-020-02042-6</doi><orcidid>https://orcid.org/0000-0002-9177-3775</orcidid></addata></record> |
fulltext | fulltext |
identifier | EISSN: 1432-1912 |
ispartof | Naunyn-Schmiedeberg's archives of pharmacology, 2021-05, Vol.394 (5), p.989 |
issn | 1432-1912 |
language | eng |
recordid | cdi_pubmed_primary_33415506 |
source | Springer Nature |
title | Evaluating the effects of 2-BFI and tracizoline, two potent I 2 -imidazoline receptor agonists, on cognitive performance and affect in middle-aged rats |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T01%3A44%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluating%20the%20effects%20of%202-BFI%20and%20tracizoline,%20two%20potent%20I%202%20-imidazoline%20receptor%20agonists,%20on%20cognitive%20performance%20and%20affect%20in%20middle-aged%20rats&rft.jtitle=Naunyn-Schmiedeberg's%20archives%20of%20pharmacology&rft.au=Hern%C3%A1ndez-Hern%C3%A1ndez,%20Elena&rft.date=2021-05&rft.volume=394&rft.issue=5&rft.spage=989&rft.pages=989-&rft.eissn=1432-1912&rft_id=info:doi/10.1007/s00210-020-02042-6&rft_dat=%3Cpubmed%3E33415506%3C/pubmed%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p108t-c361a7fdac64cdb767b9adb0196340ad1fb1dc5bf73560a42234fbb0fcc899263%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/33415506&rfr_iscdi=true |